Cargando…

Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka

The Sri Lankan Anti-Filariasis campaign distributed five rounds of mass drug administration (MDA with diethylcarbamazine plus albendazole) to some 10 million people in eight districts between 2002 and 2006. Sri Lanka was recognized by the WHO for having eliminated lymphatic filariasis (LF) as a publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Ramakrishna U., Samarasekera, Sandhya D., Nagodavithana, Kumara C., Goss, Charles W., Punchihewa, Manjula W., Dassanayaka, Tharanga D. M., Ranasinghe, Udaya S. B., Mendis, Devika, Weil, Gary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169179/ https://www.ncbi.nlm.nih.gov/pubmed/30014812 http://dx.doi.org/10.4269/ajtmh.18-0169

Ejemplares similares

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2017)

Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2016)

Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2019)

A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration
por: Rao, Ramakrishna U., et al.
Publicado: (2014)

Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2015)

The Burden of Bancroftian Filariasis in Nigeria: A Review
por: Hussaini, Adamu, et al.
Publicado: (2020)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis
por: Chhonker, Yashpal S., et al.
Publicado: (2023)

Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
por: Makunde, William H, et al.
Publicado: (2003)

A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis
por: Gass, Katherine, et al.
Publicado: (2012)

Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
por: Fernando, Sumadhya Deepika, et al.
Publicado: (2011)

Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis
por: Mand, Sabine, et al.
Publicado: (2003)

Bancroftian filariasis distribution and diurnal temperature differences in the southern Nile delta.
por: Thompson, D F, et al.
Publicado: (1996)

Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania
por: Mshana, Happyness J., et al.
Publicado: (2016)

Molecular characterisation and disease severity of leptospirosis in Sri Lanka
por: Bandara, Kanchana Kumari, et al.
Publicado: (2015)

The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea
por: Weil, Gary J., et al.
Publicado: (2008)

Economic cost of tobacco-related cancers in Sri Lanka
por: Amarasinghe, Hemantha, et al.
Publicado: (2018)

Economic costs of alcohol use in Sri Lanka
por: Ranaweera, Sajeeva, et al.
Publicado: (2018)

Filarial Antigenemia and Loa loa Night Blood Microfilaremia in an Area Without Bancroftian Filariasis in the Democratic Republic of Congo
por: Bakajika, Didier K., et al.
Publicado: (2014)

Mental health services in Sri Lanka
por: Mendis, Nalaka
Publicado: (2004)

Feasibility and Effectiveness of Basic Lymphedema Management in Leogane, Haiti, an Area Endemic for Bancroftian Filariasis
por: Addiss, David G., et al.
Publicado: (2010)

Neurological disorders associated with COVID-19 in Sri Lanka
por: Chang, Thashi, et al.
Publicado: (2023)

Cytological diagnosis of bancroftian filariasis presented as a subcutaneous swelling in the cubital fossa: an unusual presentation
por: Pandey, Pinki, et al.
Publicado: (2015)

The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia?
por: Gordon, Catherine A., et al.
Publicado: (2018)

Lymphatic Endothelial Cell in Endemic Bancroftian Filariasis: A Focus on the Lymphatics of the Tunica Vaginalis Testis
por: Figueredo-Silva, Jose, et al.
Publicado: (2018)

A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration
por: Yahathugoda, Thishan C., et al.
Publicado: (2015)

Spatial Epidemiologic Trends and Hotspots of Leishmaniasis, Sri Lanka, 2001–2018
por: Karunaweera, Nadira D., et al.
Publicado: (2020)

Human Bocavirus in Patients with Encephalitis, Sri Lanka, 2009–2010
por: Mori, Daisuke, et al.
Publicado: (2013)

Is the coverage of mass-drug-administration adequate for elimination of Bancroftian filariasis? An experience from West Bengal, India
por: Haldar, Dibakar, et al.
Publicado: (2015)

Larvicidal Activity of Cassia occidentalis (Linn.) against the Larvae of Bancroftian Filariasis Vector Mosquito Culex quinquefasciatus
por: Kumar, Deepak, et al.
Publicado: (2014)

Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Factors establishing smoke-free zones in Sri Lanka
por: Pallewaththa, Prabhath Wijitha Kumara, et al.
Publicado: (2017)

Stroke in Sri Lanka: How Can We Minimise the Burden?
por: Ranawaka, Udaya K., et al.
Publicado: (2021)

Spectrum of primary immunodeficiency disorders in Sri Lanka
por: de Silva, Nilhan Rajiva, et al.
Publicado: (2013)

Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects
por: Chandrasena, Nilmini, et al.
Publicado: (2018)

Pathological characteristics of mediastinal masses in Sri Lanka 2017–2021: a retrospective observational study
por: Mathangasinghe, Yasith, et al.
Publicado: (2022)

A Sociological Analysis and Exploration of Factors Associated with Commercial Preparations of Smokeless Tobacco Use in Sri Lanka
por: Mahees, Mohamed, et al.
Publicado: (2021)

Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/2019
por: Rannan-Eliya, Ravindra Prasan, et al.
Publicado: (2023)

Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka
por: Iddawela, Devika, et al.
Publicado: (2018)

Development and Piloting of Ascariasis Surveillance System of Children in Sri Lanka
por: Galgamuwa, Lahiru S., et al.
Publicado: (2015)

Iodine in commercial edible iodized salts and assessment of iodine exposure in Sri Lanka
por: Vithanage, Meththika, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u9h9kvgko8kbb1sfijme797fl6